Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Can a retinal implant reverse macular degeneration?

LOS ANGELES — Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive

New ways to control blood vessel growth in eye disease

In a model of abnormal eye vessel growth, removing ZEB1 made vessels grow more and become leakier. The study suggests ZEB1 controls vessel q

<![CDATA[Weighing Long-Term Survival and Quality of Life With Atezolizumab Plus Bevacizumab]]>

FDA Approves VIZZ Eye Drops for Near Vision Improvement in Presbyopia Patients

The first aceclidine-based eye drop to improve near vision in adults with age-related presbyopia, which affects more than 100 million adults

Fundusz Bezpieczeństwa i Obronności – nowe narzędzie budowania odporności Polski

Artykuł Fundusz Bezpieczeństwa i Obronności – nowe narzędzie budowania odporności Polski pochodzi z serwisu MILMAG .

Life Biosciences Begins First Human Trial of Cellular Rejuvenation Drug for Age-Related Vision Loss

It'll be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.